Atossa Therapeutics Inc

NASDAQ:ATOS   3:59:42 PM EDT
1.75
+0.01 (+0.57%)
Earnings Announcements

Atossa Therapeutics reports Q3 Loss Per Share $0.34

Published: 11/13/2020 14:37 GMT
Atossa Genetics Inc (ATOS) - Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update.
Atossa Therapeutics Qtrly Loss per Share $0.34.
Atossa Therapeutics - As of September 30, 2020, Company Had Approximately $9.2 Million in Cash and Cash Equivalents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.45

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.